FDA Inspection
RB Health (US) LLCRB Health (US) LLC – FDA Inspection, Dec 20, 2024
Record Details
This FDA Inspection record concerns RB Health (US) LLC, with an inspection on December 20, 2024, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · bdb6882e-83c0-4601-a277-d1d6769f493b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1230106
- FDA center
- Human Drugs
- Project area
- Postmarketing Surveillance and Epidemiology: Human Drugs
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 314.80(d)Failure to submit scientific article
- 21 CFR 314.80(c)(2)(ii)(B)Late submission of an ICSR
Full citation text and observation details available on the Dashboard.
Other FDA inspections of RB Health (US) LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 18, 2026 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
| May 15, 2015 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for RB Health (US) LLC
- FDA Inspection 1285364 - 2026-02-18
- FDA Inspection 926018 - 2015-05-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.